Connection
Jens Kuhn to Pyrimidine Nucleosides
This is a "connection" page, showing publications Jens Kuhn has written about Pyrimidine Nucleosides.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.891 |
|
|
|
-
Bennett RP, Postnikova EN, Eaton BP, Cai Y, Yu S, Smith CO, Liang J, Zhou H, Kocher GA, Murphy MJ, Smith HC, Kuhn JH. Sangivamycin is highly effective against SARS-CoV-2 in vitro and has favorable drug properties. JCI Insight. 2022 01 11; 7(1).
Score: 0.723
-
Bennett RP, Finch CL, Postnikova EN, Stewart RA, Cai Y, Yu S, Liang J, Dyall J, Salter JD, Smith HC, Kuhn JH. A Novel Ebola Virus VP40 Matrix Protein-Based Screening for Identification of Novel Candidate Medical Countermeasures. Viruses. 2020 Dec 31; 13(1).
Score: 0.168